News
Chronic obstructive pulmonary disease (COPD) is an irreversible inflammatory lung disease. Studies have shown that ...
8don MSN
A research team has unveiled the cause and molecular mechanism of chronic brain inflammation that results in repetitive ...
In acute respiratory distress syndrome (ARDS), inflammatory phenotypes can be classified at the bedside in real time in a ...
18d
MedPage Today on MSNNovel IL-7 Receptor Antagonist Shows Promise in Ulcerative ColitisLusvertikimab selectively inhibits IL-7 but not the thymic stromal lymphopoietin (TSLP) axis, Bourreille told attendees. A phase I study previously demonstrated lusvertikimab's sa ...
Bronchiectasis is a chronic airway suppurative disease in which recurrent airway infections, inflammation and remodeling have ...
RAF1 signalling leads to the acetylation of Toll-like receptor (TLR)-activated nuclear ... such as inducing the upregulation of interleukin-10 (IL-10). Crosstalk between the SYK and RAF1 pathways ...
Dupilumab and omalizumab are both effective adjuvant treatments for adults with bullous pemphigoid, though dupilumab may provide better outcomes.
14d
Verywell Health on MSN11 Proven Treatments to Ease PCOS Symptoms NaturallyThere are many natural ways you can help ease PCOS symptoms, like ingesting herbs and making lifestyle changes, instead of taking medications. Here’s how.
SOUTH SAN FRANCISCO, Calif., May 14, 2025 (GLOBE NEWSWIRE) -- Surrozen, Inc. (“Surrozen” or the “Company”) (Nasdaq: SRZN), a company pioneering targeted therapeutics that selectively activate the Wnt ...
Our trial provides proof of concept that cytokine-armored CAR T-cell treatment is feasible and may enhance antitumor activity without additional toxic effects,” researchers reported.
15d
Stockhead on MSNDr Boreham’s Crucible: The wheels keep turning for Dimerix and its kidney drug candidateDimerix and its kidney drug is on track but with results of its phase III trial not due for years, a few more twists and turns are likely.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results